Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Presentation for care and antenatal management of HIV in the UK, 2009-2014.

French CE, Thorne C, Byrne L, Cortina-Borja M, Tookey PA.

HIV Med. 2017 Mar;18(3):161-170. doi: 10.1111/hiv.12410. Epub 2016 Aug 1.

2.

The association between ethnicity and late presentation to antenatal care among pregnant women living with HIV in the UK and Ireland.

Tariq S, Elford J, Cortina-Borja M, Tookey PA; National Study of HIV in Pregnancy and Childhood.

AIDS Care. 2012;24(8):978-85. doi: 10.1080/09540121.2012.668284. Epub 2012 Apr 23.

PMID:
22519823
3.

Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.

Erlwanger AS, Joseph J, Gotora T, Muzunze B, Orne-Gliemann J, Mukungunugwa S, Farley T, Mangwiro AZ.

J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S198-S206. doi: 10.1097/QAI.0000000000001347.

PMID:
28498190
4.

UK national clinical audit: management of pregnancies in women with HIV.

Raffe S, Curtis H, Tookey P, Peters H, Freedman A, Gilleece Y; British HIV Association Audit and Standards Sub-Committee.

BMC Infect Dis. 2017 Feb 20;17(1):158. doi: 10.1186/s12879-017-2255-6.

5.

An augmented SMS intervention to improve access to antenatal CD4 testing and ART initiation in HIV-infected pregnant women: a cluster randomized trial.

Dryden-Peterson S, Bennett K, Hughes MD, Veres A, John O, Pradhananga R, Boyer M, Brown C, Sakyi B, van Widenfelt E, Keapoletswe K, Mine M, Moyo S, Asmelash A, Siedner M, Mmalane M, Shapiro RL, Lockman S.

PLoS One. 2015 Feb 18;10(2):e0117181. doi: 10.1371/journal.pone.0117181. eCollection 2015.

6.
7.

Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study.

Phillips T, Thebus E, Bekker LG, Mcintyre J, Abrams EJ, Myer L.

J Int AIDS Soc. 2014 Oct 8;17:19242. doi: 10.7448/IAS.17.1.19242. eCollection 2014.

8.

Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi.

Weigel R, Hosseinipour MC, Feldacker C, Gareta D, Tweya H, Chiwoko J, Gumulira J, Kalulu M, Mofolo I, Kamanga E, Mwale G, Kadzakumanja A, Jere E, Phiri S.

Trop Med Int Health. 2012 Jun;17(6):751-9. doi: 10.1111/j.1365-3156.2012.02980.x. Epub 2012 Apr 5.

9.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
10.

HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.

Myer L, Phillips TK, McIntyre JA, Hsiao NY, Petro G, Zerbe A, Ramjith J, Bekker LG, Abrams EJ.

HIV Med. 2017 Feb;18(2):80-88. doi: 10.1111/hiv.12397. Epub 2016 Jun 28.

PMID:
27353189
11.

Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria.

Rawizza HE, Chang CA, Chaplin B, Ahmed IA, Meloni ST, Oyebode T, Banigbe B, Sagay AS, Adewole IF, Okonkwo P, Kanki PJ; APIN PEPFAR Team.

Curr HIV Res. 2015;13(3):201-9.

12.

Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa.

Fatti G, Shaikh N, Eley B, Grimwood A.

AIDS Care. 2016;28 Suppl 1:114-8. doi: 10.1080/09540121.2016.1148112. Epub 2016 Feb 28.

13.

Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes.

Marazzi MC, Palombi L, Nielsen-Saines K, Haswell J, Zimba I, Magid NA, Buonomo E, Scarcella P, Ceffa S, Paturzo G, Narciso P, Liotta G.

AIDS. 2011 Aug 24;25(13):1611-8. doi: 10.1097/QAD.0b013e3283493ed0.

PMID:
21673553
14.

Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnant women with HIV in Italy.

Floridia M, Pinnetti C, Ravizza M, Frisina V, Cetin I, Fiscon M, Sansone M, Antoni AD, Guaraldi G, Vimercati A, Guerra B, Placido G, Dalzero S, Tamburrini E; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy.

HIV Clin Trials. 2014 May-Jun;15(3):104-15. doi: 10.1310/hct1503-104.

PMID:
24947534
15.

The challenge of referring HIV-positive pregnant women with treatment indication from PMTCT to ART services: a retrospective follow-up study in Mbeya, Tanzania.

Theuring S, Sewangi J, Nchimbi P, Harms G, Mbezi P.

AIDS Care. 2014;26(7):850-6. doi: 10.1080/09540121.2013.869535. Epub 2013 Dec 20.

PMID:
24359539
16.

Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women.

French CE, Tookey PA, Cortina-Borja M, de Ruiter A, Townsend CL, Thorne C.

Antivir Ther. 2013;18(2):183-92. doi: 10.3851/IMP2327. Epub 2012 Aug 22.

PMID:
23475123
17.
18.

Management and outcomes of pregnancies among women with HIV in Oxford, UK, in 2008-2012.

Montgomery-Taylor S, Hemelaar J.

Int J Gynaecol Obstet. 2015 Jul;130(1):59-63. doi: 10.1016/j.ijgo.2015.02.019. Epub 2015 Apr 11.

PMID:
25912413
19.

Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa.

Myer L, Phillips TK, Hsiao NY, Zerbe A, Petro G, Bekker LG, McIntyre JA, Abrams EJ.

J Int AIDS Soc. 2015 Jul 6;18:20045. doi: 10.7448/IAS.18.1.20045. eCollection 2015.

20.

Implementation and Operational Research: Barriers and Facilitators to Combined ART Initiation in Pregnant Women With HIV: Lessons Learnt From a PMTCT B+ Pilot Program in Swaziland.

Parker LA, Jobanputra K, Okello V, Nhlangamandla M, Mazibuko S, Kourline T, Kerschberger B, Pavlopoulos E, Teck R.

J Acquir Immune Defic Syndr. 2015 May 1;69(1):e24-30. doi: 10.1097/QAI.0000000000000537.

Supplemental Content

Support Center